Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Armani M. Hawes, Angel N. Desai, Payal Patel
Abstract
Testing for and incidence of Clostridioides difficile infection (CDI) was examined at a single center before and during the first surge of the COVID-19 pandemic. Incidence of CDI remained stable but testing statistically significantly decreased during the first surge despite an increase in antibiotic use. There were no new CDI-focused antimicrobial stewardship interventions introduced during this time.
Topics & Concepts
ClostridioidesPandemicIncidence (geometry)Coronavirus disease 2019 (COVID-19)Antimicrobial stewardshipMedicineDiagnostic test2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Psychological interventionAntibioticsVirologyInternal medicineBiologyAntibiotic resistanceEmergency medicineMicrobiologyPhysicsOutbreakInfectious disease (medical specialty)PsychiatryOpticsDiseaseClostridium difficile and Clostridium perfringens researchAntibiotic Use and ResistanceBacterial Identification and Susceptibility Testing